Drug
Vamifeport Formulation 1
Vamifeport Formulation 1: highest development phase Phase 1, developed by Vifor Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Vifor Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Vamifeport Formulation 1 NCT05077436 | Phase 1 | Healthy |
Latest
No recent events.
Follow Vamifeport Formulation 1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.